Home / Rosuvastatin / Canada
CA ATC C10AA07 · updated 2 Nov 2026
Rosuvastatin shortage in Canada
Is there a Rosuvastatin shortage in Canada?
Yes. As of 2 Nov 2026, 9 Rosuvastatin products are reported short in Canada, the first since 1 Apr 2017. The company estimate for the return is 13 Nov 2026 (latest 27 Nov 2026). Main reason: distribution or logistics.
Also short in Germany, Italy, Spain, Ireland, Austria, Belgium, Czechia, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MAR-ROSUVASTATIN (100 Tablet) | MARCAN PHARMACEUTICALS INC | 1 Apr 2017 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-ROSUVASTATIN (100 Tablet) | MARCAN PHARMACEUTICALS INC | 1 Apr 2017 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-ROSUVASTATIN (100 Tablet) | MARCAN PHARMACEUTICALS INC | 1 Apr 2017 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-ROSUVASTATIN (500 Tablet) | MARCAN PHARMACEUTICALS INC | 1 Apr 2017 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-ROSUVASTATIN (500 Tablet) | MARCAN PHARMACEUTICALS INC | 1 Apr 2017 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-ROSUVASTATIN (500 Tablet) | MARCAN PHARMACEUTICALS INC | 1 Apr 2017 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-ROSUVASTATIN (500) | MARCAN PHARMACEUTICALS INC | 10 Jul 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | APO-ROSUVASTATIN (30 BLS) | APOTEX INC | 25 Aug 2026 | 27 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-ROSUVASTATIN (500 BTL) | APOTEX INC | 22 Sep 2026 | 13 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.